APA (7th ed.) Citation

E, N., KB, G., II, P., S, T., PL, M., HF, S., . . . DH, P. (2014). MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases. British journal of cancer, 110(12), 2874. https://doi.org/10.1038/bjc.2014.263

Chicago Style (17th ed.) Citation

E, Nagy, Gajjar KB, Patel II, Taylor S, Martin-Hirsch PL, Stringfellow HF, Martin FL, and Phillips DH. "MGMT Promoter Hypermethylation and K-RAS, PTEN and TP53 Mutations in Tamoxifen-exposed and Non-exposed Endometrial Cancer Cases." British Journal of Cancer 110, no. 12 (2014): 2874. https://doi.org/10.1038/bjc.2014.263.

MLA (9th ed.) Citation

E, Nagy, et al. "MGMT Promoter Hypermethylation and K-RAS, PTEN and TP53 Mutations in Tamoxifen-exposed and Non-exposed Endometrial Cancer Cases." British Journal of Cancer, vol. 110, no. 12, 2014, p. 2874, https://doi.org/10.1038/bjc.2014.263.